Tapewire

NYSE · USD

BR

BROADRIDGE FINANCIAL SOLUTIONS, INC.

Export transactions ↓
Tapewire entity
3252
SEC CIK
0001383312
Parsed reports
1,212

Last 12 months

Inside the activity.

1 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202600
Feb 202602
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 14, 2022 Filed Feb 16, 2022 14:28 UTC
DALY RICHARD JDirector · Executive Chairman
GrantStock Option (Right to Buy) · Derivative 4,117 $0.00 Strike: $144.84 $0.00
Disclosure

SEC source: 0001225208-22-002261 · doc4.xml · derivative · entry 1

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,117

Underlying: Common Stock · 4,117 shares

Expires 2032-02-14

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 19:29 UTC
Tae Michael SCorporate VP, CTO, ICS
GrantStock Option (Right to Buy) · Derivative 6,862 $0.00 Strike: $144.84 $0.00
Disclosure

SEC source: 0001225208-22-002272 · doc4.xml · derivative · entry 2

Tae Michael S · CIK 0001663476 · Corporate VP, CTO, ICS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,312

Underlying: Common Stock · 6,862 shares

Expires 2032-02-14

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 19:29 UTC
Tae Michael SCorporate VP, CTO, ICS
GrantStock Option (Right to Buy) · Derivative 27,450 $0.00 Strike: $144.84 $0.00
Disclosure

SEC source: 0001225208-22-002272 · doc4.xml · derivative · entry 1

Tae Michael S · CIK 0001663476 · Corporate VP, CTO, ICS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,450

Underlying: Common Stock · 27,450 shares

Expires 2032-02-14

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 19:29 UTC
Stingi Richard JohnCorporate VP and CHRO
GrantStock Option (Right to Buy) · Derivative 8,235 $0.00 Strike: $144.84 $0.00
Disclosure

SEC source: 0001225208-22-002271 · doc4.xml · derivative · entry 1

Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,235

Underlying: Common Stock · 8,235 shares

Expires 2032-02-14

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 19:29 UTC
Reese EdmundCorporate VP and CFO
GrantStock Option (Right to Buy) · Derivative 24,018 $0.00 Strike: $144.84 $0.00
Disclosure

SEC source: 0001225208-22-002269 · doc4.xml · derivative · entry 1

Reese Edmund · CIK 0001833903 · Corporate VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,018

Underlying: Common Stock · 24,018 shares

Expires 2032-02-14

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 19:28 UTC
Carey Thomas PCorporate VP
GrantStock Option (Right to Buy) · Derivative 14,068 $0.00 Strike: $144.84 $0.00
Disclosure

SEC source: 0001225208-22-002260 · doc4.xml · derivative · entry 1

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,068

Underlying: Common Stock · 14,068 shares

Expires 2032-02-14

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 19:29 UTC GrantStock Option (Right to Buy) · Derivative 30,195 $0.00 Strike: $144.84 $0.00
Disclosure

SEC source: 0001225208-22-002268 · doc4.xml · derivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,195

Underlying: Common Stock · 30,195 shares

Expires 2032-02-14

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 19:29 UTC
Gumbs Keir DCVP and Chief Legal Officer
GrantStock Option (Right to Buy) · Derivative 16,607 $0.00 Strike: $144.84 $0.00
Disclosure

SEC source: 0001225208-22-002264 · doc4.xml · derivative · entry 1

Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,607

Underlying: Common Stock · 16,607 shares

Expires 2032-02-14

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 19:28 UTC
DESCHUTTER DOUGLAS RICHARDCorporate Vice President
GrantStock Option (Right to Buy) · Derivative 6,313 $0.00 Strike: $144.84 $0.00
Disclosure

SEC source: 0001225208-22-002262 · doc4.xml · derivative · entry 1

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,313

Underlying: Common Stock · 6,313 shares

Expires 2032-02-14

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023.

Read SEC document
February 14, 2022 Filed Feb 16, 2022 19:28 UTC
KALENKA ROBERT FCorporate Vice President
GrantStock Option (Right to Buy) · Derivative 6,107 $0.00 Strike: $144.84 $0.00
Disclosure

SEC source: 0001225208-22-002259 · doc4.xml · derivative · entry 2

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,107

Underlying: Common Stock · 6,107 shares

Expires 2032-02-14

F2 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023.

Read SEC document
February 04, 2022 Filed Feb 16, 2022 19:28 UTC
KALENKA ROBERT FCorporate Vice President
GiftCommon Stock 350 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002259 · doc4.xml · nonDerivative · entry 1

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,355.4097

F1 · price: The reported disposition represents a bona fide charitable gift made by the reporting person.

Read SEC document
February 01, 2022 Filed Feb 2, 2022 16:55 UTC
Reese EdmundCorporate VP and CFO
Exercise / conversionRestricted Stock Unit · Derivative 1,943 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-22-001272 · doc4.xml · derivative · entry 6

Reese Edmund · CIK 0001833903 · Corporate VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,721

Underlying: Common Stock · 1,943 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on February 1, 2022 1,943 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F2 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on February 1, 2022 1,943 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F2 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on February 1, 2022 1,943 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F2 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on February 1, 2022 1,943 Restricted Stock Units vested and converted into an equal number of shares of common stock.

Read SEC document
February 01, 2022 Filed Feb 2, 2022 16:55 UTC
Reese EdmundCorporate VP and CFO
Tax withholdingCommon Stock 1,075 $153.33 $164,829.75
Disclosure

SEC source: 0001225208-22-001272 · doc4.xml · nonDerivative · entry 4

Reese Edmund · CIK 0001833903 · Corporate VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,912

Read SEC document
February 01, 2022 Filed Feb 2, 2022 16:55 UTC
Reese EdmundCorporate VP and CFO
Exercise / conversionCommon Stock 1,943 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-001272 · doc4.xml · nonDerivative · entry 3

Reese Edmund · CIK 0001833903 · Corporate VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,987

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on February 1, 2022 1,943 Restricted Stock Units vested and converted into an equal number of shares of common stock.

Read SEC document
January 31, 2022 Filed Feb 2, 2022 16:55 UTC
Reese EdmundCorporate VP and CFO
Exercise / conversionRestricted Stock Unit · Derivative 3,021 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-22-001272 · doc4.xml · derivative · entry 5

Reese Edmund · CIK 0001833903 · Corporate VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,664

Underlying: Common Stock · 3,021 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on January 31, 2022 3,021 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on January 31, 2022 3,021 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F1 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on January 31, 2022 3,021 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F1 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on January 31, 2022 3,021 Restricted Stock Units vested and converted into an equal number of shares of common stock.

Read SEC document
January 31, 2022 Filed Feb 2, 2022 16:55 UTC
Reese EdmundCorporate VP and CFO
Tax withholdingCommon Stock 1,700 $159.22 $270,674.00
Disclosure

SEC source: 0001225208-22-001272 · doc4.xml · nonDerivative · entry 2

Reese Edmund · CIK 0001833903 · Corporate VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,044

Read SEC document
January 31, 2022 Filed Feb 2, 2022 16:55 UTC
Reese EdmundCorporate VP and CFO
Exercise / conversionCommon Stock 3,021 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-001272 · doc4.xml · nonDerivative · entry 1

Reese Edmund · CIK 0001833903 · Corporate VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,744

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on January 31, 2022 3,021 Restricted Stock Units vested and converted into an equal number of shares of common stock.

Read SEC document
January 10, 2022 Filed Aug 15, 2022 22:20 UTC
Reese EdmundCorporate VP and CFO
GrantCommon Stock 6.39 $174.33 $1,113.97
Disclosure

SEC source: 0001225208-22-009544 · doc5.xml · nonDerivative · entry 3

Reese Edmund · CIK 0001833903 · Corporate VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,742.21

F1 · shares: Represents shares of Broadridge common stock acquired through dividend reinvestment during the fiscal year.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 17:26 UTC GrantCommon Stock 63 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-000577 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,302

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 12:26 UTC GrantCommon Stock 63 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-000582 · doc4.xml · nonDerivative · entry 1

PERNA THOMAS J · CIK 0001209487 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,170

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 17:26 UTC GrantCommon Stock 1 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-000578 · doc4.xml · nonDerivative · entry 1

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 486

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 17:26 UTC
keller brettDirector
GrantCommon Stock 5 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-000579 · doc4.xml · nonDerivative · entry 2

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,950

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 17:26 UTC
keller brettDirector
GrantCommon Stock 22 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-000579 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,945

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 12:25 UTC GrantCommon Stock 91 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-000575 · doc4.xml · nonDerivative · entry 1

BRUN LESLIE A · CIK 0001217068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,493

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 17:26 UTC
Zavery AmitDirector
GrantCommon Stock 6 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-000583 · doc4.xml · nonDerivative · entry 2

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,654

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 17:26 UTC
Zavery AmitDirector
GrantCommon Stock 7 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-000583 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,648

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 17:26 UTC GrantCommon Stock 1 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-000581 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 648

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 17:26 UTC GrantCommon Stock 10 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-000580 · doc4.xml · nonDerivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,919.102

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 17:26 UTC GrantCommon Stock 41 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-000580 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,909.102

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 17:26 UTC GrantCommon Stock 11 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-000576 · doc4.xml · nonDerivative · entry 1

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,314

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
December 28, 2021 Filed Dec 28, 2021 21:49 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 466 $0.00 Strike: $98.31 $0.00
Disclosure

SEC source: 0001225208-21-015251 · doc4.xml · derivative · entry 3

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,239

Underlying: Common Stock · 466 shares

Expires 2029-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 11, 2021.

Read SEC document
December 28, 2021 Filed Dec 28, 2021 21:49 UTC SaleCommon Stock 415 $185.04 $76,791.02
Disclosure

SEC source: 0001225208-21-015251 · doc4.xml · nonDerivative · entry 2

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,639.528

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on May 11, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.00 - $185.08, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
December 28, 2021 Filed Dec 28, 2021 21:49 UTC Exercise / conversionCommon Stock 466 $98.31 $45,812.46
Disclosure

SEC source: 0001225208-21-015251 · doc4.xml · nonDerivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,054.528

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 11, 2021.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 16:22 UTC
Gumbs Keir DCVP and Chief Legal Officer
Exercise / conversionRestricted Stock Unit · Derivative 8,079 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-21-015089 · doc4.xml · derivative · entry 3

Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,057

Underlying: Common Stock · 8,079 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on December 15, 2021 8,079 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on December 15, 2021 8,079 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F1 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on December 15, 2021 8,079 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F1 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on December 15, 2021 8,079 Restricted Stock Units vested and converted into an equal number of shares of common stock.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 16:22 UTC
Gumbs Keir DCVP and Chief Legal Officer
Tax withholdingCommon Stock 3,886 $178.02 $691,785.72
Disclosure

SEC source: 0001225208-21-015089 · doc4.xml · nonDerivative · entry 2

Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,193

Read SEC document
December 15, 2021 Filed Dec 17, 2021 16:22 UTC
Gumbs Keir DCVP and Chief Legal Officer
Exercise / conversionCommon Stock 8,079 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-015089 · doc4.xml · nonDerivative · entry 1

Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,079

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on December 15, 2021 8,079 Restricted Stock Units vested and converted into an equal number of shares of common stock.

Read SEC document
December 07, 2021 Filed Dec 7, 2021 17:20 UTC
SCHIFELLITE ROBERTCorporate SVP
Exercise / conversionStock Option (Right to Buy) · Derivative 18,040 $0.00 Strike: $50.95 $0.00
Disclosure

SEC source: 0001225208-21-014551 · doc4.xml · derivative · entry 4

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,611

Underlying: Common Stock · 18,040 shares

Expires 2025-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 07, 2021 Filed Dec 7, 2021 17:20 UTC
SCHIFELLITE ROBERTCorporate SVP
SaleCommon Stock 15,063 $173.26 $2,609,830.44
Disclosure

SEC source: 0001225208-21-014551 · doc4.xml · nonDerivative · entry 3

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,604.6729

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.50 - $174.17, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
December 07, 2021 Filed Dec 7, 2021 17:20 UTC
SCHIFELLITE ROBERTCorporate SVP
SaleCommon Stock 3,000 $173.26 $519,783.00
Disclosure

SEC source: 0001225208-21-014551 · doc4.xml · nonDerivative · entry 2

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,667.6729

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.50 - $174.17, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
December 07, 2021 Filed Dec 7, 2021 17:20 UTC
SCHIFELLITE ROBERTCorporate SVP
Exercise / conversionCommon Stock 18,040 $50.95 $919,138.00
Disclosure

SEC source: 0001225208-21-014551 · doc4.xml · nonDerivative · entry 1

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,667.6729

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2021 Filed Dec 7, 2021 17:00 UTC
keller brettDirector
GrantCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-014545 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,923

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 06, 2021 Filed Dec 7, 2021 17:00 UTC
Zavery AmitDirector
GrantCommon Stock 153 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-014548 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,641

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 06, 2021 Filed Dec 7, 2021 17:00 UTC GrantCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-014547 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 647

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 06, 2021 Filed Dec 7, 2021 17:00 UTC GrantCommon Stock 184 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-014546 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,868.102

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 03, 2021 Filed Dec 6, 2021 21:19 UTC
SCHIFELLITE ROBERTCorporate SVP
Exercise / conversionStock Option (Right to Buy) · Derivative 14,960 $0.00 Strike: $50.95 $0.00
Disclosure

SEC source: 0001225208-21-014505 · doc4.xml · derivative · entry 3

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,651

Underlying: Common Stock · 14,960 shares

Expires 2025-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 03, 2021 Filed Dec 6, 2021 21:19 UTC
SCHIFELLITE ROBERTCorporate SVP
SaleCommon Stock 12,488 $173.11 $2,161,758.97
Disclosure

SEC source: 0001225208-21-014505 · doc4.xml · nonDerivative · entry 2

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,627.6729

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.00 - $173.9150, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
December 03, 2021 Filed Dec 6, 2021 21:19 UTC
SCHIFELLITE ROBERTCorporate SVP
Exercise / conversionCommon Stock 14,960 $50.95 $762,212.00
Disclosure

SEC source: 0001225208-21-014505 · doc4.xml · nonDerivative · entry 1

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,115.6729

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 29, 2021 Filed Nov 29, 2021 14:48 UTC
Mayadas VijayCorporate Vice President
Exercise / conversionStock Option (Right to Buy) · Derivative 4,029 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-21-014173 · doc4.xml · derivative · entry 18

Mayadas Vijay · CIK 0001658677 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,343

Underlying: Common Stock · 4,029 shares

Expires 2028-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 29, 2021 Filed Nov 29, 2021 14:48 UTC
Mayadas VijayCorporate Vice President
Exercise / conversionStock Option (Right to Buy) · Derivative 3,604 $0.00 Strike: $98.31 $0.00
Disclosure

SEC source: 0001225208-21-014173 · doc4.xml · derivative · entry 17

Mayadas Vijay · CIK 0001658677 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,604

Underlying: Common Stock · 3,604 shares

Expires 2029-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 29, 2021 Filed Nov 29, 2021 14:48 UTC
Mayadas VijayCorporate Vice President
Exercise / conversionStock Option (Right to Buy) · Derivative 6,299 $0.00 Strike: $67.32 $0.00
Disclosure

SEC source: 0001225208-21-014173 · doc4.xml · derivative · entry 16

Mayadas Vijay · CIK 0001658677 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,299 shares

Expires 2027-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.